• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Meet 5 companies developing novel drug-delivery devices

October 26, 2017 By Sarah Faulkner

Insulet's OmnipodInsulet, a Massachusetts-based company that sells a tubeless insulin-delivery system called the Omnipod, spoke at PODD about the process of developing a drug-delivery device that the targeted patient population will actually want to use.

“Everybody is staring down the barrel of the costs of adherence,” VP of business development Michael Graffeo said. “Everybody would like to do something about that. Collectively as a group, what I get is a great deal of angst over what do we do about that, that actually is going to make a difference? Because we’ve attempted to throw solutions at it for years. We’ve been trying to solve adherence challenges for a long time, and we’ve really made no dent in that.”

Graffeo noted that many devices are designed to simply deliver a drug at a certain volume with a particular viscosity – they’re not designed with the patient in mind.

“When you start thinking about self-administration, you start to deal with the real world. You start to deal with real people with real preferences and real habits. This is where things get tangled and messy,” he explained.

“Making products that people love matters. It matters a great deal. At least at Insulet we come from a perspective where we know that it matters because our patients wear devices all day, every day, from now to the rest of their lives. See, you can’t put something on somebody and have them go, ‘I don’t really like it, but I’ll put up with it.’

We keep chasing better adherence with solutions that actually decrease adherence. When we start by understanding the patient working together collaboratively, we have a fighting chance to actually answer these questions,” he added.

Next >>

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6

Filed Under: Auto-injectors, Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Becton Dickinson, Bespak, Enable Injections, Insulet, Pfizer Inc., West Pharmaceutical Services

IN CASE YOU MISSED IT

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS